Engineering DNA nicking endonucleases

工程 DNA 切口核酸内切酶

基本信息

  • 批准号:
    7119677
  • 负责人:
  • 金额:
    $ 28.42万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-09-05 至 2008-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In Phase I, the cviPIIM, cviPIINt, cviQXIM, cviQXINt genes were cloned and sequenced. Recombinant Nt.CviPII was expressed in E.coli and purified. Nt.CviQXI was expressed in E.coli and by an in vitro transcription/translation system. Nt.Sapl and Nb.Sapl were engineered from Sapl endonuclease using a novel two-step genetic selection procedure. Under Phase II funding, we will optimize the expression conditions for Nt.CviPII and Nt.CviQXI to alleviate cytotoxicity. Constitutive expression of M.CviPII and M.CviQXI will be achieved to fully modify host DNA. Nt.CviPII and Nt.CviQXI NEases will be expressed in pACYC-T7. In addition, C-terminal truncation variants of Nt.CviPII and Nt.CviQXI will be constructed (in fusion with intein and chitin binding domain). Synthetic peptides will be ligated to the truncated versions via intein-mediated peptide ligation to construct full-length enzymes. Secondary amino acid (aa) substitutions will be introduced into Nb.Sapl to optimize the nicking activity and eliminate dsDNA cleavage. The equivalent aa changes will be introduced into BspQI (a thermostable Sapl isoschizomer) to isolate N.BspQI. Sapl and Earl share similar DNA recognition sequences and the aa sequences of the two endonucleases display a high level of similarity. The aa changes that resulted in Sapl nicking variants will be introduced into Earl endonuclease to isolate N.Earl. We will isolate nicking variants from a 4-base cutter Mnll (CCTCN7 A, ANeGAGG). Extremely thermostable nicking variants will also be isolated from Tth111II (CAARCA11/9) that is active at 75 degrees C. We will engineer nicking variants from homing endonucleases l-Scel and l-Dmol with15-18 bp recognition sequences. We will clone and characterize HNH type homing endonucleases from chlorella virus genomes. In Phase I, we discovered a novel DNA amplification method using Nt.CviPII and Bst DNA polymerase. Random DNA amplification has been achieved from a small amount of genomic DNA or from a single bacterial colony without addition of exogenous primers. Under Phase II funding, this isothermal amplification method (NEMDA) will be optimized and the sensitivity will be improved. Finally, we will investigate the potential of NEMDA for detections of pathogens and its use in bio-prospecting.
描述(由申请人提供): 在第一阶段,克隆了cviPIIM、cviPIINt、cviQXIM、cviQXINt基因。重组Nt.CviPII在大肠杆菌中表达并纯化。Nt.CviQXI在大肠杆菌中表达,并通过体外转录/翻译系统进行表达。Nt.Sap1和Nb.Sap1是通过一种新的两步遗传选择程序从Sap1内切酶中获得的。在第二阶段的资助下,我们将优化Nt.CviPII和Nt.CviQXI的表达条件,以减轻细胞毒性。实现M.CviPII和M.CviQXI的组成性表达,以充分修饰宿主DNA。Nt.CviPII和Nt.CviQXI NEase将在pACYC-T7中表达。此外,还将构建Nt.CviPII和Nt.CviQXI的C-末端截断变体(与内含素和几丁质结合域融合)。合成肽将通过内含素介导的肽连接连接到截短的版本上,以构建全长酶。Nb.Sapl将引入二次氨基酸(AA)取代,以优化其划痕活性并消除dsDNA切割。等量的AA变化将引入BspQI(一种耐热的Sapl异构体)以分离N.BspQI。SAPL和Earl具有相似的DNA识别序列,两种内切酶的AA序列显示出很高的相似性。导致Sapl划痕变异的AA变化将被引入Earl内切酶中,以分离N.Earl。我们将从4碱基刀具Mnll(CCTCN7 A,ANeGAGG)中分离出划痕变体。还将从75℃下活跃的Tth111II(CAARCA11/9)中分离出极耐热的划痕变异体。我们将从归巢内切酶L-SCEL和L-Dmol中设计具有15-18个核苷酸识别序列的划痕变异体。我们将从小球藻病毒基因组中克隆和鉴定HNH型归巢内切酶。在第一阶段,我们发现了一种利用Nt.CviPII和BST DNA聚合酶进行DNA扩增的新方法。从少量的基因组DNA或从单个细菌菌落中进行随机DNA扩增,无需添加外源引物。在第二阶段的资助下,这种等温放大方法(NEMDA)将得到优化,灵敏度将得到提高。最后,我们将研究NEMDA在病原体检测方面的潜力及其在生物勘探中的应用。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Discovery of natural nicking endonucleases Nb.BsrDI and Nb.BtsI and engineering of top-strand nicking variants from BsrDI and BtsI.
  • DOI:
    10.1093/nar/gkm481
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    14.9
  • 作者:
    Xu, Shuang-Yong;Zhu, Zhenyu;Zhang, Penghua;Chan, Siu-Hong;Samuelson, James C;Xiao, Jianping;Ingalls, Debra;Wilson, Geoffrey G
  • 通讯作者:
    Wilson, Geoffrey G
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHUANG-YONG XU其他文献

SHUANG-YONG XU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHUANG-YONG XU', 18)}}的其他基金

A Genetic System Able to Screen for Active DNA Demethylation
能够筛选活性 DNA 去甲基化的遗传系统
  • 批准号:
    7107041
  • 财政年份:
    2006
  • 资助金额:
    $ 28.42万
  • 项目类别:
A universal DNA endonuclease
通用 DNA 核酸内切酶
  • 批准号:
    6875448
  • 财政年份:
    2005
  • 资助金额:
    $ 28.42万
  • 项目类别:
Engineering DNA nicking endonucleases
工程 DNA 切口核酸内切酶
  • 批准号:
    6989821
  • 财政年份:
    2005
  • 资助金额:
    $ 28.42万
  • 项目类别:
Cloning and Engineering of Nicking enzymes
切口酶的克隆和工程
  • 批准号:
    6737237
  • 财政年份:
    2004
  • 资助金额:
    $ 28.42万
  • 项目类别:

相似海外基金

Mechanisms of Cellular Senescence Driving Intervertebral Disc Aging through Local Cell Autonomous and Systemic Non-Cell Autonomous Processes
细胞衰老通过局部细胞自主和全身非细胞自主过程驱动椎间盘老化的机制
  • 批准号:
    10635092
  • 财政年份:
    2023
  • 资助金额:
    $ 28.42万
  • 项目类别:
Studies of Chemically Labile Alkylation Damage in DNA
DNA 中化学不稳定烷基化损伤的研究
  • 批准号:
    10735154
  • 财政年份:
    2023
  • 资助金额:
    $ 28.42万
  • 项目类别:
In vivo prime editing for precision cancer mouse models
精准癌症小鼠模型的体内 Prime 编辑
  • 批准号:
    10735971
  • 财政年份:
    2023
  • 资助金额:
    $ 28.42万
  • 项目类别:
tRNA-derived RNA Fragments (tRF) as Prognostic and Diagnostic Biomarkers for Alzheimer’s Disease
tRNA 衍生的 RNA 片段 (tRF) 作为阿尔茨海默病的预后和诊断生物标志物
  • 批准号:
    10578546
  • 财政年份:
    2023
  • 资助金额:
    $ 28.42万
  • 项目类别:
Ref-1 in Retinal Neovascularization
Ref-1 在视网膜新生血管中的作用
  • 批准号:
    10679621
  • 财政年份:
    2023
  • 资助金额:
    $ 28.42万
  • 项目类别:
LINE1-ORF0 in SLE pathogenesis
SLE 发病机制中的 LINE1-ORF0
  • 批准号:
    10681876
  • 财政年份:
    2023
  • 资助金额:
    $ 28.42万
  • 项目类别:
Role of DNA damage and cellular senescence in osteoarthritis pathophysiology
DNA 损伤和细胞衰老在骨关节炎病理生理学中的作用
  • 批准号:
    10801026
  • 财政年份:
    2023
  • 资助金额:
    $ 28.42万
  • 项目类别:
Integration of single-cell imaging and multi-omics sequencing to study EC mechano-pathophysiology
整合单细胞成像和多组学测序来研究 EC 机械病理生理学
  • 批准号:
    10825307
  • 财政年份:
    2023
  • 资助金额:
    $ 28.42万
  • 项目类别:
Consequences of retrotransposition on genome integrity
逆转录转座对基因组完整性的影响
  • 批准号:
    10736406
  • 财政年份:
    2023
  • 资助金额:
    $ 28.42万
  • 项目类别:
Mechanism for post-transcriptional gene regulation by Ribothrypsis
核糖体转录后基因调控机制
  • 批准号:
    10639411
  • 财政年份:
    2023
  • 资助金额:
    $ 28.42万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了